Factors Indicating Need for Dose Escalation Increase doses when minimal subjective improvements after 3-4 weeks at current dose, IGF-1 levels show minimal or no meaningful increase from baseline after an adequate trial period (e.g., 812 weeks), good tolerance without significant side effects suggesting room for higher dosing, and treatment goals require more aggressive approach than current dose provides
The aforementioned outcomes are accomplished through a range of mechanisms, including upregulating the expression of endothelial nitric oxide synthase (eNOS), enhancing the phosphorylation of eNOS at Ser1177, downregulating the expression of NADPH oxidase (NOX), increasing the levels of tetrahydrobiopterin (BH4) in the vasculature through GCH1-dependent pathways, and restoring the coupling of eNOS to facilitate the availability of NO (105)
The cream has a lightweight yet nourishing texture, restoring comfort to the skin from the first application
In addition to damaging muscle cell membranes and mitochondrial function, lipid peroxidation exacerbates muscle atrophy by inducing muscle cell death
GHK-Cu Storage Method Comparison Refrigeration vs Freezing vs Room Temp Key Takeaways Store GHK-Cu after reconstitution at 28C in a sealed, refrigerated container
This method is unlikely to cause negative side effects